The global transvaginal endoscopy market is anticipated to grow at a significant CAGR of 7.3% during the forecast period. Some of the prominent factors driving the market growth during the forecast period include the rising incidence of infertility among the female rising incidence of infertility globally, coupled with the increasing use of minimally invasive surgery. The MIS procedures involves minminal use of surgical incisions, and with the advent of laproscopic surgery, the MIS are highly used for performing transvaginal endoscopy. Disorders of the ovaries, such as polycystic ovarian syndrome (PCOS)and other follicular disorders, are the basic cause of infertility in women. As per American Society for Reproductive Medicine report publish in 2021, stats that nearly 7.4 million women in the US or approximately 12.1% of women of reproductive age experience difficulty having children due of impaired fecundity. Moreover, according to WHO, infertility may be caused by a range of abnormalities of the uterus, and the endocrine system, among others. In September 2020, nearly 48 million couples and 186 million individuals are suffered form infertility disease across the globe.
Browse the full report description of “Global Transvaginal Endoscopy Market Size, Share & Trends Analysis Report by Type (Capsule Endoscopy, and Robot-Assisted Endoscopy), by Devices (Flexible Endoscopic Devices, and Rigid Endoscopic Devices), and by End User (Hospital, and Clinics) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/transvaginal-endoscopy-market
Moreover, as per CDC, the percentage of women aged 15-49 years with impaired fecundity, by parity in 2019 was 13.8%. As per, the Department of economics and social affairs, the global level of fertility is expected to reach 2.2 live births per woman in 2050, and 1.9 in 2100. Hence, the rapid rise in infertility among women across the globe is anticipated to acceleratemarket growth in the coming year.
The Lenox Instrument Co., Optim LLC, PENTAX Europe GmbH, and Richard Wolf Gmbh are the key companies operating in the industry that are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. whichis anticipated to growth. For instance, in November 2021, RoundTable Healthcare Partners announced that its portfolio company, Healthcare Components Group(HCG), has acquired an endoscopy development company. The acquisition aims to enhance the offering of components used in the development and repair of endoscopes to their customers.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Devices
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape-includesCardinal Health, Inc., Hologic Inc., Johnson & Johnson Inc., Olympus Corp., Stryker Corp., Endo Gastric Solutions Inc., Endoservice GmbH, KARL STORZ, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected region/segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Transvaginal Endoscopy Market– Segmentation
By Type
By Devices
By End-User
Global Transvaginal Endoscopy Market by Region
North America
• US
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/transvaginal-endoscopy-market